Want to see JP:7062 full AI Analyst Report?
Top Page
fureasu Co., Ltd.
(7062)
Select Model
Select Model
Rating:64Neutral
Price Target:
¥776.00
▼(-2.88% Downside)
Action:Reiterated
Date:08/18/26
The score is driven primarily by the FY2026 financial recovery (profits back to positive, deleveraging, and strong free cash flow) and very low valuation (P/E ~3.13). These positives are tempered by weak technicals (below key moving averages with bearish momentum) and the risk that the rebound may be uneven given recent revenue decline and historically volatile cash flow.
Positive Factors
Profitability Recovery
The return to profitability and higher gross margin indicate improved operating economics. If maintained, this recovery can strengthen internal funding, support service investment, and reduce dependence on external financing.
Negative Factors
Revenue Contraction
Revenue contraction raises concern about demand, client acquisition, or service capacity across the home-care platform. Without a return to durable top-line growth, the recent profit improvement may remain vulnerable to fixed-cost and volume pressures.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability Recovery
The return to profitability and higher gross margin indicate improved operating economics. If maintained, this recovery can strengthen internal funding, support service investment, and reduce dependence on external financing.
Read all positive factors
fureasu Co., Ltd. (7062) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥1.83B
Dividend Yield1.53%
Average Volume (3M)7.51K
Price to Earnings (P/E)3.0
Beta (1Y)0.89
Revenue Growth-17.66%
EPS GrowthN/A
CountryJP
Employees761
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)194.57
Shares Outstanding2,608,600
10 Day Avg. Volume7,710
30 Day Avg. Volume7,513
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.96
Price to Sales (P/S)0.28
P/FCF Ratio3.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
fureasu Co., Ltd. Business Overview & Revenue Model
Company Description
Fureasu Co.,Ltd. is a Japanese company specializing in therapeutic massage services, massage franchise operations, and a diverse range of care solutions. Its therapeutic offerings encompass in-home acupuncture, moxibustion treatments, on-site corp...
How the Company Makes Money
null...
fureasu Co., Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
68
Positive
Cash Flow
58
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.64B | 7.58B | 5.71B | 4.58B | 4.17B |
| Gross Profit | 3.46B | 3.20B | 2.69B | 2.24B | 2.08B |
| EBITDA | 482.72M | 200.26M | 319.35M | 200.51M | 332.47M |
| Net Income | 508.92M | -244.55M | 58.30M | 31.59M | 147.85M |
Balance Sheet | |||||
| Total Assets | 5.39B | 8.70B | 6.19B | 4.54B | 3.39B |
| Cash, Cash Equivalents and Short-Term Investments | 1.62B | 815.00M | 1.13B | 975.26M | 1.21B |
| Total Debt | 2.14B | 6.14B | 3.48B | 2.09B | 995.35M |
| Total Liabilities | 3.21B | 7.15B | 4.43B | 2.81B | 1.67B |
| Stockholders Equity | 2.18B | 1.55B | 1.77B | 1.73B | 1.72B |
Cash Flow | |||||
| Free Cash Flow | 564.46M | -456.86M | 41.91M | -317.08M | 166.38M |
| Operating Cash Flow | 590.56M | -319.20M | 172.02M | -233.15M | 309.27M |
| Investing Cash Flow | 801.62M | -354.88M | -193.60M | -516.91M | -149.47M |
| Financing Cash Flow | -589.96M | 358.26M | 177.13M | 511.11M | -160.97M |
fureasu Co., Ltd. Technical Analysis
Negative
799.00
Price Trends
760.30
Negative
785.16
Negative
806.57
Negative
Market Momentum
-21.53
Positive
29.07
Positive
20.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7062, the sentiment is Negative. The current price of 799 is above the 20-day moving average (MA) of 759.40, above the 50-day MA of 760.30, and below the 200-day MA of 806.57, indicating a bearish trend. The MACD of -21.53 indicates Positive momentum. The RSI at 29.07 is Positive, neither overbought nor oversold. The STOCH value of 20.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7062.
fureasu Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥17.20B | 10.85 | ― | 2.67% | 23.42% | 36.65% | |
72 Outperform | ¥5.96B | 10.57 | ― | 3.47% | 2.02% | -32.58% | |
71 Outperform | ¥17.91B | 11.25 | ― | 2.82% | 7.92% | 74.91% | |
68 Neutral | ¥7.54B | 9.52 | ― | 2.04% | 11.58% | 22.79% | |
64 Neutral | ¥1.83B | 2.99 | ― | ― | -17.66% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | ¥10.59B | 38.38 | ― | 5.06% | ― | ― |
* General Sector Average
JP:7062
fureasu Co., Ltd.
693.00
-217.00
-23.85%
JP:4331
Take and Give. Needs Co., Ltd.
735.00
-63.55
-7.96%
JP:7040
SUN-LIFE HOLDING CO., LTD.
973.00
34.48
3.67%
JP:7358
Poppins Corporation
1,849.00
368.01
24.85%
JP:7523
Art Vivant Co., Ltd.
1,878.00
816.77
76.96%
JP:9262
SILVER LIFE CO.,LTD.
688.00
-73.15
-9.61%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.